The management of neoplastic colorectal obstruction with colonic endolumenal stenting devices

Guy J C Harris, Anthony J. Senagore, Ian C. Lavery, Victor W. Fazio

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

Background: Colonic endolumenal stenting (CELS) to treat obstructing colorectal neoplasms was first described in 1991. The aim of this study was to review the published world literature and make recommendations for its use in current clinical practice. Methods: Suitable English language reports were identified using a Medline search. Results: CELS can been successfully accomplished in 64% to 100% of obstructing malignant colonic lesions. Distal lesions are more common and theoretically more easy to stent although lesions within the ascending colon have been successfully managed. Minor complications include transient anorectal pain and rectal bleeding, however, significant complications of stent dislocation and colonic perforation are also well recognized. Conclusion: CELS can aid the palliative management of malignant colorectal obstruction. Its role in relieving obstruction prior to resection remains to be defined. Increasing experience has allowed the safe placement of stents and relief of obstruction of virtually any lesion throughout the large bowel.

Original languageEnglish (US)
Pages (from-to)499-506
Number of pages8
JournalAmerican Journal of Surgery
Volume181
Issue number6
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Stents
Equipment and Supplies
Ascending Colon
Colorectal Neoplasms
Language
Hemorrhage
Pain

Keywords

  • Colorectal cancer
  • Endoscopy
  • Stents

ASJC Scopus subject areas

  • Surgery

Cite this

The management of neoplastic colorectal obstruction with colonic endolumenal stenting devices. / Harris, Guy J C; Senagore, Anthony J.; Lavery, Ian C.; Fazio, Victor W.

In: American Journal of Surgery, Vol. 181, No. 6, 2001, p. 499-506.

Research output: Contribution to journalArticle

Harris, Guy J C ; Senagore, Anthony J. ; Lavery, Ian C. ; Fazio, Victor W. / The management of neoplastic colorectal obstruction with colonic endolumenal stenting devices. In: American Journal of Surgery. 2001 ; Vol. 181, No. 6. pp. 499-506.
@article{59143808b6de450f92d6155d1cc63f0e,
title = "The management of neoplastic colorectal obstruction with colonic endolumenal stenting devices",
abstract = "Background: Colonic endolumenal stenting (CELS) to treat obstructing colorectal neoplasms was first described in 1991. The aim of this study was to review the published world literature and make recommendations for its use in current clinical practice. Methods: Suitable English language reports were identified using a Medline search. Results: CELS can been successfully accomplished in 64{\%} to 100{\%} of obstructing malignant colonic lesions. Distal lesions are more common and theoretically more easy to stent although lesions within the ascending colon have been successfully managed. Minor complications include transient anorectal pain and rectal bleeding, however, significant complications of stent dislocation and colonic perforation are also well recognized. Conclusion: CELS can aid the palliative management of malignant colorectal obstruction. Its role in relieving obstruction prior to resection remains to be defined. Increasing experience has allowed the safe placement of stents and relief of obstruction of virtually any lesion throughout the large bowel.",
keywords = "Colorectal cancer, Endoscopy, Stents",
author = "Harris, {Guy J C} and Senagore, {Anthony J.} and Lavery, {Ian C.} and Fazio, {Victor W.}",
year = "2001",
doi = "10.1016/S0002-9610(01)00622-5",
language = "English (US)",
volume = "181",
pages = "499--506",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - The management of neoplastic colorectal obstruction with colonic endolumenal stenting devices

AU - Harris, Guy J C

AU - Senagore, Anthony J.

AU - Lavery, Ian C.

AU - Fazio, Victor W.

PY - 2001

Y1 - 2001

N2 - Background: Colonic endolumenal stenting (CELS) to treat obstructing colorectal neoplasms was first described in 1991. The aim of this study was to review the published world literature and make recommendations for its use in current clinical practice. Methods: Suitable English language reports were identified using a Medline search. Results: CELS can been successfully accomplished in 64% to 100% of obstructing malignant colonic lesions. Distal lesions are more common and theoretically more easy to stent although lesions within the ascending colon have been successfully managed. Minor complications include transient anorectal pain and rectal bleeding, however, significant complications of stent dislocation and colonic perforation are also well recognized. Conclusion: CELS can aid the palliative management of malignant colorectal obstruction. Its role in relieving obstruction prior to resection remains to be defined. Increasing experience has allowed the safe placement of stents and relief of obstruction of virtually any lesion throughout the large bowel.

AB - Background: Colonic endolumenal stenting (CELS) to treat obstructing colorectal neoplasms was first described in 1991. The aim of this study was to review the published world literature and make recommendations for its use in current clinical practice. Methods: Suitable English language reports were identified using a Medline search. Results: CELS can been successfully accomplished in 64% to 100% of obstructing malignant colonic lesions. Distal lesions are more common and theoretically more easy to stent although lesions within the ascending colon have been successfully managed. Minor complications include transient anorectal pain and rectal bleeding, however, significant complications of stent dislocation and colonic perforation are also well recognized. Conclusion: CELS can aid the palliative management of malignant colorectal obstruction. Its role in relieving obstruction prior to resection remains to be defined. Increasing experience has allowed the safe placement of stents and relief of obstruction of virtually any lesion throughout the large bowel.

KW - Colorectal cancer

KW - Endoscopy

KW - Stents

UR - http://www.scopus.com/inward/record.url?scp=0034890927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034890927&partnerID=8YFLogxK

U2 - 10.1016/S0002-9610(01)00622-5

DO - 10.1016/S0002-9610(01)00622-5

M3 - Article

C2 - 11513773

AN - SCOPUS:0034890927

VL - 181

SP - 499

EP - 506

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 6

ER -